Transthyretin Amyloidosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-09-18
Clinical Trial Update: Evaluation of a Claims-based Algorithm for the Identification of Transthyretin-mediated Amyloidosis (ATTR) Amyloidosis in Medical Records [EARLY_Phase 1]
A Phase 1 study evaluating a claims-based algorithm to identify transthyretin amyloidosis in medical records was withdrawn.